Abstract
Due to their short half-life and diffusion away from the site of regeneration, osteogenic proteins, used in regenerative medicine, require high doses leading to undesirable side effects. An exciting approach is to utilize peptides derived from the active domains of soluble and insoluble components of the bone extracellular matrix (ECM) to initiate the cascade of osteogenesis, vasculogenesis, mineralization, and bone formation. Osteogenic peptides derived from bone morphogenetic proteins, integrin-binding and heparin-binding peptides, collagen-derived peptides, peptides derived from bone sialoprotein and enamel matrix proteins, vasoconstrictive peptides, peptides derived from the histone proteins involved in the structure of chromatin and those derived from receptor-binding domain of human thrombin, peptides that abolish the expression of tumor necrosis factor-α, and neuropeptides have been discovered. In this work, anabolic effects of osteogenic peptides in particular with respect to cell adhesion, differentiation, and mineralization are discussed. These peptides show significantly higher biological activity in vitro and in vivo, in small animal models, when immobilized in a matrix by conjugation or grafting, most likely due to the peptide mobility and its diffusion away from the site of regeneration. Combination of osteogenic and integrin- binding peptides synergistically enhances cell adhesion and mineralization. Functionalization of orthopedic implants with osteogenic peptides can improve cell adhesion, mineralization, and overall integration of the implant with the surrounding tissue, which in turn reduces implant loosening and failure. The use of osteogenic peptides as an alternative growth factor in orthopedic applications rests on future in vivo studies that evaluate these peptides in primates and humans.
Keywords: Osteogenic peptides, anabolic effect, osteoprogenitor cells, differentiation, mineralization, osteogenic marker expression.
Current Pharmaceutical Design
Title:Osteogenic Peptides in Bone Regeneration
Volume: 19 Issue: 19
Author(s): Esmaiel Jabbari
Affiliation:
Keywords: Osteogenic peptides, anabolic effect, osteoprogenitor cells, differentiation, mineralization, osteogenic marker expression.
Abstract: Due to their short half-life and diffusion away from the site of regeneration, osteogenic proteins, used in regenerative medicine, require high doses leading to undesirable side effects. An exciting approach is to utilize peptides derived from the active domains of soluble and insoluble components of the bone extracellular matrix (ECM) to initiate the cascade of osteogenesis, vasculogenesis, mineralization, and bone formation. Osteogenic peptides derived from bone morphogenetic proteins, integrin-binding and heparin-binding peptides, collagen-derived peptides, peptides derived from bone sialoprotein and enamel matrix proteins, vasoconstrictive peptides, peptides derived from the histone proteins involved in the structure of chromatin and those derived from receptor-binding domain of human thrombin, peptides that abolish the expression of tumor necrosis factor-α, and neuropeptides have been discovered. In this work, anabolic effects of osteogenic peptides in particular with respect to cell adhesion, differentiation, and mineralization are discussed. These peptides show significantly higher biological activity in vitro and in vivo, in small animal models, when immobilized in a matrix by conjugation or grafting, most likely due to the peptide mobility and its diffusion away from the site of regeneration. Combination of osteogenic and integrin- binding peptides synergistically enhances cell adhesion and mineralization. Functionalization of orthopedic implants with osteogenic peptides can improve cell adhesion, mineralization, and overall integration of the implant with the surrounding tissue, which in turn reduces implant loosening and failure. The use of osteogenic peptides as an alternative growth factor in orthopedic applications rests on future in vivo studies that evaluate these peptides in primates and humans.
Export Options
About this article
Cite this article as:
Jabbari Esmaiel, Osteogenic Peptides in Bone Regeneration, Current Pharmaceutical Design 2013; 19 (19) . https://dx.doi.org/10.2174/1381612811319190006
DOI https://dx.doi.org/10.2174/1381612811319190006 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
When BMP Signalling Goes Wrong: The Intracellular and Molecular Mechanisms of BMP Signalling in Cancer
Current Signal Transduction Therapy Molecular Function of Tocopherols in Age Related Diseases
Current Pharmaceutical Design Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Recent Patents on Anti-Cancer Drug Discovery Wharton's Jelly Mesenchymal Stem Cell Response on Chitosan-graft-poly (ε-caprolactone) Copolymer for Myocardium Tissue Engineering
Current Pharmaceutical Design Chemical and Medicinal Versatility of Substituted 1,4-Dihydropyridines
Current Bioactive Compounds Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging
Current Medicinal Chemistry GnRH Agonists and Antagonists in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Subject Index to Volume 10
Current Medicinal Chemistry Atrial Macroreentry in Congenital Heart Disease
Current Cardiology Reviews Cyclin-dependent kinase Inhibitors Inspired by Roscovitine: Purine Bioisosteres
Current Pharmaceutical Design Digitalis-like Compounds: the Discovery of the O-aminoalkyloxime Group as a Very Powerful Substitute for the Unsaturated γ-Butyrolactone Moiety
Current Medicinal Chemistry Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)
Current Pharmaceutical Design Inhibitors of ABL and the ABL-T315I Mutation
Current Topics in Medicinal Chemistry Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Obesity and Metabolic Syndrome Affect the Cholinergic Transmission a nd Cognitive Functions
CNS & Neurological Disorders - Drug Targets Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Vascular Endothelial Dysfunction
Current Drug Targets Surfing the Blood Coagulation Cascade: Insight into the Vital Factor Xa
Current Medicinal Chemistry Lipid Rafts, Endoplasmic Reticulum and Mitochondria in the Antitumor Action of the Alkylphospholipid Analog Edelfosine
Anti-Cancer Agents in Medicinal Chemistry G Protein-Coupled Receptors and their Signaling Pathways: Classical Therapeutical Targets Susceptible to Novel Therapeutic Concepts
Current Pharmaceutical Design Roles of CLR/RAMP Receptor Signaling in Reproduction and Development
Current Protein & Peptide Science